Gene: MYNN
Official Full Name: myoneurinprovided by HGNC
Gene Summary: This gene encodes a member of the BTB/POZ and zinc finger domain-containing protein family that are involved in the control of gene expression. Alternative splicing results in multiple transcript variants and a pseudogene has been identified on chromosome 14. [provided by RefSeq, Jun 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15948 | MYNN Knockout cell line (HeLa) | Human | MYNN | 1:3~1:6 | Negative | Online Inquiry |
KO15949 | MYNN Knockout cell line (HCT 116) | Human | MYNN | 1:2~1:4 | Negative | Online Inquiry |
KO15950 | MYNN Knockout cell line (HEK293) | Human | MYNN | 1:3~1:6 | Negative | Online Inquiry |
KO15951 | MYNN Knockout cell line (A549) | Human | MYNN | 1:3~1:4 | Negative | Online Inquiry |
MYNN Gene Knockout Cell Lines are a sophisticated biological tool designed to facilitate gene functional studies by providing researchers with a platform to explore the effects of knocking out the MYNN gene in various cellular contexts. These cell lines have been meticulously engineered to carry specific deletions of the MYNN gene, enabling detailed investigations into its role in cellular processes such as signal transduction, differentiation, and tumorigenesis. By utilizing CRISPR-Cas9 technology, we ensure that the knockout cells exhibit high precision in gene editing, significantly enhancing the reliability of experimental outcomes.
The key function of the MYNN Gene Knockout Cell Lines lies in their ability to elucidate the biological importance of the MYNN gene within both normal and pathological states. Research utilizing these cell lines can provide insights into the mechanisms of MYNN-related disorders, allowing for the development of targeted therapeutic strategies. In clinical settings, understanding this gene’s function can lead to more precise interventions for diseases where MYNN plays a pivotal role.
What distinguishes our MYNN Gene Knockout Cell Lines from alternatives is the comprehensive validation of gene knockout efficiency and the stability of the resulting phenotype. Our product’s performance in various in vitro assays guarantees consistent and reproducible results, an essential requirement for any significant research endeavor. Furthermore, we offer outstanding technical support and resources to optimize the utilization of our cell lines, fostering a productive research environment.
Researchers and clinicians will find our MYNN Gene Knockout Cell Lines invaluable for unraveling the complexities of gene functions in health and disease. Our commitment to delivering high-quality biological products ensures that you have the tools necessary to drive discoveries that could lead to novel therapeutic strategies.
With a legacy of scientific excellence and innovation, our company specializes in advanced cell culture solutions and genomic technology, making us a trusted partner in your research and development efforts.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.